KfW is a German state-owned development bank.
Business Model:
Revenue: $3.1B
Employees: 5,001-10,000
Address: Palmengartenstrasse 5-9
City: Frankfurt am Main
State: hesse
Zip: 60325
Country: DE
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sized enterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2006 | Micropelt | Series A | 6M |
5/2012 | Micropelt | Venture Round | 8.5M |
1/2008 | Protagen | Venture Round | 1.5M |
12/2015 | meventi Deutschland | Venture Round | - |
12/2016 | amcure | Series B | 6.3M |
10/2006 | numares HEALTH | Venture Round | 2.5M |
2/2017 | smartB | Series A | - |
1/2014 | smartB | Series A | 5.4M |
9/2015 | Biametrics GmbH | Series A | 3.5M |
11/2008 | OXID eSales | Venture Round | - |
6/2018 | IL&a;FS Transportation Networks | Post-IPO Debt | 27.6M |
12/2015 | Trinckle | Seed Round | 0 |
8/2013 | CorTec | Series A | 4M |
12/2012 | clickworker | Venture Round | 0 |
9/2012 | Orpheus GmbH | Seed Round | - |
3/2022 | HelloDuty | Grant | 111.3k |
9/2012 | GOVECS | Venture Round | 12.6M |
10/2012 | Zalando | Debt Financing | 52.6M |
9/2007 | Galantos Pharma | Series B | 3.8M |
1/2022 | Electrochaea | Series D | 0 |
6/2011 | Cynora | Series A | 6.6M |
5/2010 | apprupt | Series A | - |
10/2012 | avandeo | Venture Round | - |
3/2013 | SIRION BIOTECH | Venture Round | - |
7/2021 | InsuResilience Investment Fund | Grant | 53.2M |
1/2015 | Shelter Afrique | Debt Financing | 50M |
3/2006 | VERTILAS | Series C | 4.3M |
8/2009 | Protagen | Venture Round | 5.3M |
2/2016 | Hemovent | Series A | 6M |
10/2009 | Nevigo (Articy) | Private Equity Round | - |
11/2009 | ELARA Pharmaceuticals | Series A | 6.9M |
3/2011 | bettermarks | Venture Round | 4.2M |
3/2016 | nello | Seed Round | 760.6k |
9/2009 | Stream5 | Venture Round | - |
7/2006 | Art of Defence | Series A | 2.9M |
8/2013 | Capical GmbH | Series A | - |
11/2014 | Electrochaea | Series A | - |
6/2011 | NonWoTecc Medical | Series B | 10.1M |
10/2018 | pflege.de | Venture Round | 0 |
6/2011 | Vimecon | Venture Round | - |
5/2010 | bettermarks | Venture Round | 6.1M |
4/2014 | Streetspotr | Seed Round | - |
9/2010 | VIOSO | Series B | 401.6k |
9/2015 | Datapine | Series A | 0 |
9/2018 | Veact | Series B | - |
9/2008 | QuinLogic | Seed Round | 2.3M |
11/2015 | Cleverciti | Seed Round | 0 |
3/2017 | OMEICOS Therapeutics | Series B | 0 |
11/2008 | Ubitexx | Series B | 1.9M |
12/2008 | Lieferando | Seed Round | - |
7/2016 | Arzneimittelwerk Warngau | Series C | 6.6M |
1/2011 | sones | Series A | - |
9/2011 | Sividon Diagnostics | Private Equity Round | - |
10/2020 | Cleverciti | Series A | 0 |
1/2014 | pflege.de | Series A | 1.6M |
1/2009 | Novaled | Series C | 0 |
7/2005 | Art of Defence | Venture Round | 359k |
4/2022 | Polygenta Technologies | Debt Financing | 0 |
5/2018 | Implandata Ophthalmic Products | Series C | - |
2/2010 | Cuculus | Series B | 0 |
8/2012 | evidanza | Series C | 5.1M |
2/2021 | GetYourGuide | Debt Financing | 0 |
7/2010 | locr | Venture Round | - |
6/2018 | Eskom Holdings | Debt Financing | 100M |
4/2015 | Eskom Holdings | Debt Financing | 339M |
6/2014 | meventi Deutschland | Venture Round | - |
10/2005 | Phenex Pharmaceuticals | Series A | 5M |
4/2020 | Adidas | Post-IPO Debt | - |
6/2013 | Serfides | Seed Round | 2.6M |
9/2010 | GreenPocket | Series A | 2.1M |
1/2012 | Intelligent Apps | Series B | 13M |
8/2009 | CorporateWorld | Series B | - |
2/2016 | readfy | Seed Round | - |
12/2011 | pflege.de | Venture Round | - |
5/2010 | Galantos | Series C | 5.7M |
10/2014 | Implandata Ophthalmic Products | Series B | 0 |
11/2008 | VIOSO | Series A | 1.3M |
1/2008 | DIVOLUTION | Venture Round | - |
10/2011 | numares HEALTH | Venture Round | 9.5M |
5/2007 | KINAXO Biotechnologies | Series A | - |
8/2008 | Signature Diagnostics GmbH | Series C | 7.6M |
10/2008 | Phenex Pharmaceuticals | Series B | 11.4M |
8/2005 | Hyglos | Series C | 0 |
4/2017 | nello | Seed Round | 1.6M |
2/2013 | Orpheus GmbH | Series A | - |
8/2008 | Protagen | Venture Round | - |
6/2013 | Pactas GmbH | Venture Round | - |
5/2014 | Tixxt | Venture Round | - |
5/2011 | Protectimmun GmbH | Seed Round | - |
5/2008 | studdex | Angel Round | 278.5k |
5/2012 | simplesurance | Seed Round | - |
2/2011 | FAIRRANK GmbH | Venture Round | - |
2/2009 | sofatronic | Series B | - |
7/2012 | Customer Alliance | Series B | - |
12/2009 | numares HEALTH | Venture Round | 5.7M |
12/2016 | Acousia Therapeutics | Series A | 0 |
9/2012 | Augmentation Industries | Seed Round | 1.9M |
1/2022 | Uniper | Post-IPO Debt | 0 |
2/2013 | ZooRoyal | Venture Round | - |
4/2009 | Metasonic AG | Venture Round | - |
11/2007 | Sloning BioTechnology | Series E | 6.8M |
11/2016 | DiGiConsul | Debt Financing | - |
9/2009 | Sloning BioTechnology | Venture Round | - |
6/2015 | Mandulis Energy | Grant | 170k |
4/2011 | OctreoPharm Sciences | Venture Round | 7.2M |
5/2005 | Sloning BioTechnology | Series C | 3.9M |
8/2015 | 8select | Seed Round | 1.5M |
12/2021 | NamPower | Grant | 0 |
3/2021 | Productsup | Debt Financing | 0 |
8/2020 | EFTA | Venture Round | 0 |
4/2009 | KeyNeurotek Pharmaceuticals | Series C | 10.9M |
6/2021 | Electrochaea | Venture Round | - |
12/2010 | Blue Lion Mobile (QEEP) | Series B | - |
12/2005 | Novaled | Series B | 0 |
12/2009 | Curetis | Series A | 27.9M |
6/2006 | Innolume | Series B | 9M |
11/2012 | RegioHelden | Series A | - |
4/2017 | BigRep | Series B | 15M |
12/2014 | WeSustain | Series B | 0 |
6/2006 | NanoCompound | Series B | 1.9M |
1/2007 | Voipfuture | Seed Round | - |
5/2016 | Unidesq | Seed Round | - |
1/2014 | flinc GmbH | Venture Round | - |
7/2014 | AYOXXA | Series B | 12.1M |
11/2007 | INCHRON | Venture Round | - |
11/2015 | Sicoya | Series A | 3.8M |
6/2011 | SIRION BIOTECH | Venture Round | - |
5/2018 | Acousia Therapeutics | Series B | 0 |
5/2018 | advanceCOR | Venture Round | 7.1M |
5/2012 | Algiax Pharmaceuticals | Series A | 5.5M |
7/2008 | SuppreMol | Series B | 25M |
10/2015 | Veact | Series A | 3M |
11/2009 | Confovis | Seed Round | - |
7/2016 | fromAtoB | Series A | 10.5M |
8/2019 | GNA Biosolutions | Series C | 0 |
11/2015 | BigRep | Series A | 0 |
2/2007 | immatics biotechnologies | Series B | 52.1M |
7/2012 | Subitec | Series B | 5.5M |
7/2011 | Pay by Shopping (deal united) | Series B | - |
7/2014 | predict.io | Seed Round | 680.3k |
12/2010 | ubigrate | Series B | - |
4/2015 | OMEICOS Therapeutics | Series A | 0 |
7/2016 | CryoTherapeutics | Series B | 0 |
1/2011 | GILUPI | Series C | 0 |
3/2011 | intelligent fluids GmbH | Series B | 1.7M |
7/2020 | kraftwerk TUBES GmbH | Convertible Note | 562.6k |
6/2015 | Minodes | Seed Round | 1.4M |
5/2010 | Caprotec Bioanalytics | Series B | 5.1M |
5/2008 | locr | Angel Round | 1.7M |
7/2008 | Biontis | Venture Round | - |
4/2013 | miacosa | Venture Round | - |
5/2006 | SuppreMol | Series A | 0 |
12/2011 | Zitra.com | Seed Round | - |
3/2015 | GNA Biosolutions | Series B | 0 |
1/2008 | Cytocentrics | Venture Round | 1.4M |
2/2015 | rankingCoach | Venture Round | - |
7/2006 | t2cure | Series A | - |
9/2010 | Phenex Pharmaceuticals | Series C | 0 |
11/2015 | aquila biolabs | Seed Round | - |
2/2011 | SAW Instruments | Series B | 1.4M |
10/2013 | Schutzklick | Venture Round | - |
6/2020 | CureVac | Venture Round | 340.2M |
2/2012 | numares HEALTH | Venture Round | 9.5M |
10/2015 | NEUWAY Pharma | Series A | 3.5M |
11/2010 | Placetel | Private Equity Round | - |
9/2011 | apprupt | Series B | - |
9/2007 | Emporis | Venture Round | - |
2/2011 | INCHRON | Venture Round | - |
3/2010 | clickworker | Series A | 0 |
3/2011 | clickworker | Series B | 6M |
10/2010 | Zimory | Venture Round | 5.5M |
11/2018 | OMEICOS Therapeutics | Series C | 0 |
10/2011 | Humedics | Series A | - |
7/2017 | Hemovent | Series A | 2.3M |
12/2010 | SuppreMol | Series C | 20.4M |
4/2022 | Polygenta Technologies | Debt Financing | 0 |
1/2022 | Electrochaea | Series D | 0 |
1/2022 | Uniper | Post-IPO Debt | 0 |
12/2021 | NamPower | Grant | 0 |
7/2021 | InsuResilience Investment Fund | Grant | 0 |
6/2021 | Electrochaea | Venture Round | - |
3/2021 | Productsup | Debt Financing | 0 |
2/2021 | GetYourGuide | Debt Financing | 0 |
10/2020 | Cleverciti | Series A | 0 |
8/2020 | EFTA | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|